Publications by authors named "Mariette Botes"

Claim this Profile
A
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
T Sonia Boender, Cissy M Kityo, Ragna S Boerma, Raph L Hamers, Pascale Ondoa, Mariette E Botes

J Antimicrob Chemother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
T Sonia Boender, Raph L Hamers, Pascale Ondoa, Maureen Wellington, Cleophas Chimbetete, Mariette E Botes

J Infect Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The end of the line? A case of drug resistance to third-line antiretroviral therapy.
Theresa M Rossouw, Sonia Hitchcock, Mariëtte Botes

South Afr J HIV Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
T Sonia Boender, Bernice M Hoenderboom, Kim C E Sigaloff, Raph L Hamers, Maureen Wellington, Mariette E Botes

Clin Infect Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
David A Cooper, Jayvant Heera, Prudence Ive, Mariette Botes, Edwin Dejesus

AIDS· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy.
Timothy Eley, Shu-Pang Huang, Francesca Conradie, Carmen D Zorrilla, Deirdre Josipovic, Mariëtte Botes

AIDS Res Hum Retroviruses· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
Raph L Hamers, Hans L Zaaijer, Carole L Wallis, Margaret Siwale, Prudence Ive, Mariette E Botes

J Acquir Immune Defic Syndr· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.
Kim C E Sigaloff, Raph L Hamers, Carole L Wallis, Cissy Kityo, Margaret Siwale, Mariette E Botes

J Infect Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
Raph L Hamers, Kim C E Sigaloff, Annemarie M Wensing, Carole L Wallis, Cissy Kityo, Mariette E Botes

Clin Infect Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network.
Raph L Hamers, Elske Straatsma, Cissy Kityo, Carole L Wallis, Wendy S Stevens, Mariette E Botes

Clin Infect Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
Kim C E Sigaloff, Raph L Hamers, Jack Menke, Moheb Labib, Margaret Siwale, Mariette E Botes

Clin Infect Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.
Raph L Hamers, Rob Schuurman, Kim C E Sigaloff, Carole L Wallis, Cissy Kityo, Mariette E Botes

Lancet Infect Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.
Raph L Hamers, Rebecca Oyomopito, Cissy Kityo, Praphan Phanuphak, Margaret Siwale, Mariette E Botes

Int J Epidemiol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Raph L Hamers, Carole L Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Mariette E Botes

Lancet Infect Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa.
Kim C E Sigaloff, Raph L Hamers, Carole L Wallis, Cissy Kityo, Margaret Siwale, Mariette E Botes

J Acquir Immune Defic Syndr· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis